aluates Reports

$ 0.0

Automative

Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Research Report 2024

Published Date: September 2024

Report Code: QYRE-Auto-21J18270

BUY CHAPTERS

Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Research Report 2024

Code: QYRE-Auto-21J18270

Report

September 2024

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Recordati Rare Diseases

Grand Pharmaceutical Group

Medunik

Acer Therapeutics

Sigmapharm Laboratories

Amgen Inc

Immedica

Sovereign Medical

Lee's Pharmaceuticals

N-Acetylglutamate Synthetase Deficiency (NAGSD) Market

N-Acetylglutamate Synthase Deficiency (NAGS Deficiency) is a rare inherited metabolic disorder and a member of the urea cycle disorders (UCDs). The urea cycle converts toxic ammonia in the body into non-toxic urea, which is excreted from the body through the kidneys.

The global N-Acetylglutamate Synthetase Deficiency (NAGSD) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for N-Acetylglutamate Synthetase Deficiency (NAGSD) in Adults is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of N-Acetylglutamate Synthetase Deficiency (NAGSD) include Recordati Rare Diseases, Grand Pharmaceutical Group, Sovereign Medical, Lee's Pharmaceuticals, Medunik, Acer Therapeutics, Sigmapharm Laboratories, Amgen, Immedica, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for N-Acetylglutamate Synthetase Deficiency (NAGSD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding N-Acetylglutamate Synthetase Deficiency (NAGSD).

The N-Acetylglutamate Synthetase Deficiency (NAGSD) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global N-Acetylglutamate Synthetase Deficiency (NAGSD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the N-Acetylglutamate Synthetase Deficiency (NAGSD) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Report

Report Metric	Details
Report Name	N-Acetylglutamate Synthetase Deficiency (NAGSD) Market
Segment by Type	Original Drug Generic Drug
Segment by Application	Adults Children
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Recordati Rare Diseases, Grand Pharmaceutical Group, Sovereign Medical, Lee's Pharmaceuticals, Medunik, Acer Therapeutics, Sigmapharm Laboratories, Amgen, Immedica
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of N-Acetylglutamate Synthetase Deficiency (NAGSD) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the N-Acetylglutamate Synthetase Deficiency (NAGSD) Market report?

Ans: The main players in the N-Acetylglutamate Synthetase Deficiency (NAGSD) Market are Recordati Rare Diseases, Grand Pharmaceutical Group, Sovereign Medical, Lee's Pharmaceuticals, Medunik, Acer Therapeutics, Sigmapharm Laboratories, Amgen, Immedica

What are the Application segmentation covered in the N-Acetylglutamate Synthetase Deficiency (NAGSD) Market report?

Ans: The Applications covered in the N-Acetylglutamate Synthetase Deficiency (NAGSD) Market report are Adults, Children

What are the Type segmentation covered in the N-Acetylglutamate Synthetase Deficiency (NAGSD) Market report?

Ans: The Types covered in the N-Acetylglutamate Synthetase Deficiency (NAGSD) Market report are Original Drug, Generic Drug

Recommended Reports

Genetic Diseases

Metabolic Disorders

Deficiency Treatments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Original Drug

1.2.3 Generic Drug

1.3 Market by Application

1.3.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Adults

1.3.3 Children

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Perspective (2019-2030)

2.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Growth Trends by Region

2.2.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Historic Market Size by Region (2019-2024)

2.2.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Region (2025-2030)

2.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Dynamics

2.3.1 N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Trends

2.3.2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Drivers

2.3.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Challenges

2.3.4 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Players by Revenue

3.1.1 Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Players by Revenue (2019-2024)

3.1.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Players (2019-2024)

3.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue

3.4 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Concentration Ratio

3.4.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue in 2023

3.5 Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD) Head office and Area Served

3.6 Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Product and Application

3.7 Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 N-Acetylglutamate Synthetase Deficiency (NAGSD) Breakdown Data by Type

4.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Historic Market Size by Type (2019-2024)

4.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Type (2025-2030)

5 N-Acetylglutamate Synthetase Deficiency (NAGSD) Breakdown Data by Application

5.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Historic Market Size by Application (2019-2024)

5.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2019-2030)

6.2 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2019-2024)

6.4 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2019-2030)

7.2 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2019-2024)

7.4 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2019-2030)

8.2 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2019-2024)

8.4 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2019-2030)

9.2 Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2019-2024)

9.4 Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2019-2030)

10.2 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2019-2024)

10.4 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Recordati Rare Diseases

11.1.1 Recordati Rare Diseases Company Details

11.1.2 Recordati Rare Diseases Business Overview

11.1.3 Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction

11.1.4 Recordati Rare Diseases Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

11.1.5 Recordati Rare Diseases Recent Development

11.2 Grand Pharmaceutical Group

11.2.1 Grand Pharmaceutical Group Company Details

11.2.2 Grand Pharmaceutical Group Business Overview

11.2.3 Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction

11.2.4 Grand Pharmaceutical Group Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

11.2.5 Grand Pharmaceutical Group Recent Development

11.3 Sovereign Medical

11.3.1 Sovereign Medical Company Details

11.3.2 Sovereign Medical Business Overview

11.3.3 Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction

11.3.4 Sovereign Medical Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

11.3.5 Sovereign Medical Recent Development

11.4 Lee's Pharmaceuticals

11.4.1 Lee's Pharmaceuticals Company Details

11.4.2 Lee's Pharmaceuticals Business Overview

11.4.3 Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction

11.4.4 Lee's Pharmaceuticals Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

11.4.5 Lee's Pharmaceuticals Recent Development

11.5 Medunik

11.5.1 Medunik Company Details

11.5.2 Medunik Business Overview

11.5.3 Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction

11.5.4 Medunik Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

11.5.5 Medunik Recent Development

11.6 Acer Therapeutics

11.6.1 Acer Therapeutics Company Details

11.6.2 Acer Therapeutics Business Overview

11.6.3 Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction

11.6.4 Acer Therapeutics Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

11.6.5 Acer Therapeutics Recent Development

11.7 Sigmapharm Laboratories

11.7.1 Sigmapharm Laboratories Company Details

11.7.2 Sigmapharm Laboratories Business Overview

11.7.3 Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction

11.7.4 Sigmapharm Laboratories Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

11.7.5 Sigmapharm Laboratories Recent Development

11.8 Amgen

11.8.1 Amgen Company Details

11.8.2 Amgen Business Overview

11.8.3 Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction

11.8.4 Amgen Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

11.8.5 Amgen Recent Development

11.9 Immedica

11.9.1 Immedica Company Details

11.9.2 Immedica Business Overview

11.9.3 Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction

11.9.4 Immedica Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

11.9.5 Immedica Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Recordati Rare Diseases

Grand Pharmaceutical Group

Medunik

Acer Therapeutics

Sigmapharm Laboratories

Amgen Inc

Immedica

Sovereign Medical

Lee's Pharmaceuticals

List of Tables

Table 1. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Original Drug

Table 3. Key Players of Generic Drug

Table 4. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2019-2024)

Table 8. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2025-2030)

Table 10. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Trends

Table 11. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Drivers

Table 12. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Challenges

Table 13. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Restraints

Table 14. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Players (2019-2024)

Table 16. Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) as of 2023)

Table 17. Ranking of Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Headquarters and Area Served

Table 20. Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Product and Application

Table 21. Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Type (2019-2024)

Table 25. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Type (2025-2030)

Table 27. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Application (2019-2024)

Table 29. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Application (2025-2030)

Table 31. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2025-2030) & (US$ Million)

Table 46. Recordati Rare Diseases Company Details

Table 47. Recordati Rare Diseases Business Overview

Table 48. Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Product

Table 49. Recordati Rare Diseases Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024) & (US$ Million)

Table 50. Recordati Rare Diseases Recent Development

Table 51. Grand Pharmaceutical Group Company Details

Table 52. Grand Pharmaceutical Group Business Overview

Table 53. Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Product

Table 54. Grand Pharmaceutical Group Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024) & (US$ Million)

Table 55. Grand Pharmaceutical Group Recent Development

Table 56. Sovereign Medical Company Details

Table 57. Sovereign Medical Business Overview

Table 58. Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Product

Table 59. Sovereign Medical Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024) & (US$ Million)

Table 60. Sovereign Medical Recent Development

Table 61. Lee's Pharmaceuticals Company Details

Table 62. Lee's Pharmaceuticals Business Overview

Table 63. Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Product

Table 64. Lee's Pharmaceuticals Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024) & (US$ Million)

Table 65. Lee's Pharmaceuticals Recent Development

Table 66. Medunik Company Details

Table 67. Medunik Business Overview

Table 68. Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Product

Table 69. Medunik Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024) & (US$ Million)

Table 70. Medunik Recent Development

Table 71. Acer Therapeutics Company Details

Table 72. Acer Therapeutics Business Overview

Table 73. Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Product

Table 74. Acer Therapeutics Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024) & (US$ Million)

Table 75. Acer Therapeutics Recent Development

Table 76. Sigmapharm Laboratories Company Details

Table 77. Sigmapharm Laboratories Business Overview

Table 78. Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Product

Table 79. Sigmapharm Laboratories Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024) & (US$ Million)

Table 80. Sigmapharm Laboratories Recent Development

Table 81. Amgen Company Details

Table 82. Amgen Business Overview

Table 83. Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Product

Table 84. Amgen Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024) & (US$ Million)

Table 85. Amgen Recent Development

Table 86. Immedica Company Details

Table 87. Immedica Business Overview

Table 88. Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Product

Table 89. Immedica Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024) & (US$ Million)

Table 90. Immedica Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. Authors List of This Report

List of Figures

Figure 1. N-Acetylglutamate Synthetase Deficiency (NAGSD) Picture

Figure 2. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type: 2023 VS 2030

Figure 4. Original Drug Features

Figure 5. Generic Drug Features

Figure 6. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application: 2023 VS 2030

Figure 8. Adults Case Studies

Figure 9. Children Case Studies

Figure 10. N-Acetylglutamate Synthetase Deficiency (NAGSD) Report Years Considered

Figure 11. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region: 2023 VS 2030

Figure 14. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Players in 2023

Figure 15. Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue in 2023

Figure 17. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2019-2030)

Figure 19. United States N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2019-2030)

Figure 23. Germany N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2019-2030)

Figure 31. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2019-2030)

Figure 39. Mexico N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2019-2030)

Figure 43. Turkey N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. UAE N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Recordati Rare Diseases Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

Figure 47. Grand Pharmaceutical Group Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

Figure 48. Sovereign Medical Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

Figure 49. Lee's Pharmaceuticals Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

Figure 50. Medunik Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

Figure 51. Acer Therapeutics Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

Figure 52. Sigmapharm Laboratories Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

Figure 53. Amgen Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

Figure 54. Immedica Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Urea Cycle Disorders UCD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Urea Cycle Disorder Agent Market Research Report 2024

Global Argininemia Drugs Market Insights Forecast to 2030

Global Arginase Deficiency Drugs Market Insights Forecast to 2030

Global Arginase Deficiency Therapeutics Market Insights Forecast to 2030

Global Arginase Deficiency Treatment Market Insights Forecast to 2030

Inherited Metabolic Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Argininemia Treatment Market Insights Forecast to 2030

Adenosine Deaminase Deficiency Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ornithine Transcarbamylase Deficiency Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adenosine Deaminase Deficiency Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adenosine Deaminase Deficiency Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adenosine Deaminase Deficiency Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biotinidase Deficiency Market Research Report 2024

Global Pompe Disease Treatment Market Research Report 2024

Global Peptide Based Metabolic Disorders Therapeutics Market Research Report 2024

Congenital Adrenal Hyperplasia CAH Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alpha Antitrypsin Deficiency Treatment Market Research Report 2025

Global Acute Hyperammonemia Treatment Drugs Market Research Report 2024

RELATED REPORTS

Global Taurine and Derivatives Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26D19461

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global OTC Hydrotalcite Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18S16538

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Women's Fat Burners Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14W1499

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Yohimbine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Y1251

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions